A clinical trail to study the efficacy and safety of two types of dinoprostone medication ( single application of slow release vaginal insert VS multiple dose gel) for labor initiation
Not Applicable
- Conditions
- Health Condition 1: O80- Encounter for full-term uncomplicated delivery
- Registration Number
- CTRI/2022/06/043188
- Lead Sponsor
- Sultan Qaboos University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Applicable
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Singleton pregnancy
Term pregnancy of 37 weeks or more
Cephalic presentation Bishop score 6 or less, Intact or ruptured membranes. The following women will be excluded.
Exclusion Criteria
Previous scared uterus (cesarean section, extensive myomectomy involving the uterine cavity, previous uterine rupture or dehiscence), Para 4 or more, multiple pregnancy, estimated fetal weight more than 4 kilograms, abnormal CTG (cardiotocogram). Any contraindication for vaginal delivery (placenta previa, malpresentation, active genital herpes infection). Women with contraindication or hypersensitive to dinoprostone.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method